Immuno-Oncology
The AJMC® Immuno-Oncology compendium is a comprehensive resource for clinical news and expert insights for treatments that utilize the body's immune system to fight cancer, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapies.
Latest News
September 15th 2024
Clinical research presented at the European Society for Medical Oncology Congress 2024 highlights the significant survival benefits of perioperative and neoadjuvant immunotherapy with nivolumab and nivolumab plus ipilimumab, while emphasizing the role of biomarkers, such as circulating tumor DNA and KRAS mutations, in guiding treatment decisions.
ASCO 2024: Advances in Non-Small Cell Lung Cancer
A panel of experts discuss the value of biomarker testing for non-small cell lung cancer without driver mutations and strategies to optimize the outcomes of targeted therapies.
